Pharmacokinetics, Tolerability, and Safety of Doravirine and Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate Fixed-Dose Combination Tablets in Adolescents Living With HIV: Week 24 Results From IMPAACT 2014 : JAIDS Journal of Acquired Immune Deficiency Syndromes

Secondary Logo

Journal Logo

Clinical Science

Pharmacokinetics, Tolerability, and Safety of Doravirine and Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate Fixed-Dose Combination Tablets in Adolescents Living With HIV: Week 24 Results From IMPAACT 2014

Melvin, Ann J. MD, MPHa; Yee, Ka Lai PhDb; Gray, Kathryn P. PhDc,d; Yedla, Mounika PharmD, MPHd; Wan, Hong PhDb; Tobin, Nicole H. MDe; Teppler, Hedy MDb; Campbell, Havilland BSb; McCarthy, Katie MPHf; Scheckter, Rachel MPHf; Aurpibul, Linda MDg; Ounchanum, Pradthana MDh; Rungmaitree, Supattra MDi; Cassim, Hassena MBChBj; McFarland, Elizabeth MDk; Flynn, Patricia MDl; Cooper, Ellen MDm; Krotje, Chelsea MPHn; Townley, Ellen MSN, FNPo; Moye, Jack MDp; Best, Brookie M. PharmDq;  for the IMPAACT 2014 study team

Author Information
JAIDS Journal of Acquired Immune Deficiency Syndromes 92(2):p 153-161, February 1, 2023. | DOI: 10.1097/QAI.0000000000003116

Abstract

Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.

You can read the full text of this article if you:

Access through Ovid